Stockreport

Alector Reports Second Quarter 2020 Financial Results and Provides Corporate Update

Alector, Inc.  (ALEC) 
Last alector, inc. earnings: 3/24 04:05 pm Check Earnings Report
PDF Pivotal Phase 3 trial of AL001 initiated for treatment of frontotemporal dementia due to a progranulin gene mutation (FTD-GRN)Promising preliminary data from AL001 Phase [Read more]